The demand for sterile fill-finish services has outpaced available capacity, leading to extended wait times and delayed clinical trials for sponsors. In response, Syngene is launching a state-of-art Sterile Fill-Finish facility, building upon our years of sterile fill formulation development expertise to develop and manufacture:
Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for small-scale, sterile drug products having short development timelines. Our facility offers drug substance (DS) and drug product (DP) development and manufacturing for both small molecules and biologics.
Syngene’s Sterile Fill-Finish facility is custom-built to meet your company’s clinical and small-scale commercial needs.
Deciding on a partner for drug product (DP) development and clinical supply manufacturing for both small molecule and biologics is one of the most critical decisions the sponsor makes on its program. Syngene has proven its ability to consistently provide:
Syngene offers more than just fill/finish of sterile injectables. Strong technical capabilities and broad parenteral resources help us align with your company’s clinical/commercial objectives and our shared goal of “putting science to work”Brochure: Sterile Fill-Finish facility: Your integrated partner for customized clinical supplies